Bridgeway Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-39,690
| Closed | -$341K | – | 1321 |
|
|
2021
Q4 | $341K | Hold |
39,690
| – | – | 0.01% | 1071 |
|
|
2021
Q3 | $334K | Hold |
39,690
| – | – | 0.01% | 1131 |
|
|
2021
Q2 | $322K | Sell |
39,690
-8,379
| -17% | -$68K | 0.01% | 1197 |
|
|
2021
Q1 | $422K | Buy |
48,069
+1,284
| +3% | +$11.3K | 0.01% | 1136 |
|
|
2020
Q4 | $525K | Sell |
46,785
-715
| -2% | -$8.02K | 0.01% | 939 |
|
|
2020
Q3 | $445K | Hold |
47,500
| – | – | 0.01% | 945 |
|
|
2020
Q2 | $87K | Buy |
47,500
+36,250
| +322% | +$66.4K | ﹤0.01% | 1249 |
|
|
2020
Q1 | $19K | Hold |
11,250
| – | – | ﹤0.01% | 1251 |
|
|
2019
Q4 | $32K | Hold |
11,250
| – | – | ﹤0.01% | 1288 |
|
|
2019
Q3 | $65K | Buy |
+11,250
| New | +$65K | ﹤0.01% | 1263 |
|